Famotack 40mg 10pcs

Indications of Famotack 40

Famotidine is indicated for-

An antacid is Famotack 20. Your stomach produces less acid as a result of it. Heartburn, indigestion, and other symptoms brought on by too much stomach acid are treated and prevented by using it. Additionally, it is used to treat and prevent reflux illness, stomach ulcers, and a few other uncommon disorders. Famotack 20 is frequently recommended to prevent heartburn and stomach ulcers brought on by the use of analgesics.

Pharmacology

Famotidine is a histamine H2-receptor antagonist. Famotidine completely inhibits the action of histamine on H2-receptors of the parietal cell. It inhibits basal, overnight, and pentagastrin-stimulated gastric acid secretion. The H2-receptor antagonist activity of Famotidine is slowly reversible since the drug dissociates slowly from H2-receptor.

Dosage & Administration

Tablet:

For gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastrointestinal hemorrhage, reflux esophagitis, and Zollinger-Ellison syndrome: The usual dose for adults: is Famotidine 20 mg twice daily (after breakfast and after supper or before bedtime) or Famotidine 40 mg can be administered orally once daily at bedtime.

For the treatment of acute gastritis, and chronic gastritis in the acute exacerbation stage: The usual dosage for adults is Famotidine 20 mg orally twice a day (after breakfast and after supper or before bedtime). Also, Famotidine 40 mg can be orally administered once a day (before bedtime), and dosage should be adjusted according to age and symptoms. Most ulcer patients heal within 4-8 weeks. For maintenance therapy, the recommended oral dose is 20 mg once daily. Or, as directed by the registered physician.

Powder for Suspension:
Gastroesophageal Reflux Disease(GERD):

• <1 year of age: 0.5 mg/kg/dose of famotidine oral suspension up to 8 weeks once daily in patients
• Age 3 to 11 months: 0.5 mg/kg/dose twice daily up to 8 weeks
• Age 1 to 2 months: 0.5 mg/kg/dose once daily up to 8 weeks
• Neonates: 0.5 mg/kg/dose maximum once daily up to 8 weeks

Patients 1-16 years of age:

• Gastroesophageal Reflux Disease(GERD): 1 mg/kg/day p.o. divided b.i.d. up to 40 mg b.i.d.
• Duodenal ulcer: 0.5 mg/kg/day p.o. at bedtime or divided b.i.d. up to 40 mg/day.
• Peptic ulcer: 0.5 mg/kg/day p.o. at bedtime or divided b.i.d. up to 40 mg/day.
• Maintenance therapy: 40 mg daily at night.
• Reflux esophagitis: 2 mg/kg/day
• Zollinger-Ellison Syndrome: 40 mg 3 times daily

Interaction of Famotack 40

Famotidine does not interact with the cytochrome P450-linked drug-metabolizing enzyme system. So, no interactions have been found in men with Warfarin, Theophylline, Phenytoin, Diazepam, Propranolol, Aminopyrine, or antipyrine.

Contraindications

There are no known contraindications to Famotidine. If any evidence of hypersensitivity appears, the therapy should be discontinued and consultation with a physician is required.

Side Effects of Famotack 40

Famotidine is generally well tolerated and side effects are uncommon. Dizziness, headache, constipation, and diarrhea have been reported rarely. Other side effects reported less frequently include dry mouth, nausea and/or vomiting, rash, abdominal discomfort, anorexia, and fatigue.

Pregnancy & Lactation

Pregnancy: There are no adequate, well-controlled studies on Famotidine in pregnancy, but it is known to cross the placenta and should be prescribed only if clearly needed.

Lactation: It is not known whether Famotidine is secreted into human milk, nursing mothers should either stop nursing or stop taking the drug.

Precautions & Warnings

Dosage reduction should be considered or the interval between doses should be prolonged if creatinine clearance falls to or below 30 ml/min.

Storage Conditions

Tablet: Store between 15-30° C. Concentrate for injection: Store between 2-8° C.